M1 1 H1 conventional D2 - Brown University...Microsoft PowerPoint - Biomed 370-Treatment of...
Transcript of M1 1 H1 conventional D2 - Brown University...Microsoft PowerPoint - Biomed 370-Treatment of...
![Page 1: M1 1 H1 conventional D2 - Brown University...Microsoft PowerPoint - Biomed 370-Treatment of Schizophrenia Author Bobs Computer Created Date 2/15/2005 7:53:34 AM ...](https://reader033.fdocuments.us/reader033/viewer/2022050105/5f43f2c7eab0cf19ff78db48/html5/thumbnails/1.jpg)
1
H1M1
D2
1
conventional antipsychotic
drug
11-7 Stahl S M, Essential Psychopharmacology (2000)
pure D2 blocker
11-2 Stahl S M, Essential Psychopharmacology (2000)
Increase in negative
symptoms
11-3 Stahl S M, Essential Psychopharmacology (2000)
Mesocortical pathway
![Page 2: M1 1 H1 conventional D2 - Brown University...Microsoft PowerPoint - Biomed 370-Treatment of Schizophrenia Author Bobs Computer Created Date 2/15/2005 7:53:34 AM ...](https://reader033.fdocuments.us/reader033/viewer/2022050105/5f43f2c7eab0cf19ff78db48/html5/thumbnails/2.jpg)
2
EPSs
11-4 Stahl S M, Essential Psychopharmacology (2000)
Nigrostriatal pathway
Blockade of receptors in the nigrostriataldopamine pathway causes them to up-regulate
This up-regulation may lead to tardive dyskinesia
11-5 Stahl S M, Essential Psychopharmacology (2000)
Motor and mental features of neuroleptic-induced extrapyramidal side effects
Parkinsonism Tremor (resting), rigidity, bradykinesia, masklike facies
Akathisia Restlessness, pacing, fidgeting, shifting from jitteriness, anxiety, irritability, anger, difficulty concentrating
Dystonia Muscle contractions, tongue protrusion, torticollis, opisthotonos, fear, distress, paranoia
Tardive Buccolingual-masticatory movements of irregular dyskinesia (nonrhythmic) nature; choreiform or athetoid
(writhing) movements of fingers, extremities, trunk
Adapted from Ayd 1995; Casey 1995
![Page 3: M1 1 H1 conventional D2 - Brown University...Microsoft PowerPoint - Biomed 370-Treatment of Schizophrenia Author Bobs Computer Created Date 2/15/2005 7:53:34 AM ...](https://reader033.fdocuments.us/reader033/viewer/2022050105/5f43f2c7eab0cf19ff78db48/html5/thumbnails/3.jpg)
3
D2 receptor prolactin
D2 antagonist
11-32 Stahl S M, Essential Psychopharmacology (2000)
pituitary lactotroph
Typical antipsychotic drugs: potencies and side effect profiles
Drug Approximate Sedative Hypotensive Anticholinergic Extrapyramidaldose (mg) effect effect effect effect
PhenothiazinesChlorpromazine (Thorazine) 100 H H M L
PiperidinesThioridazine (Mellaril) 95 H H H L
PiperazinesFluphenazine (Prolixin) 2 M L L HPerphenazine (Trilafon) 8 L L L HTrifluoperazine (Stelazine) 5 M L L H
ThioxantheneThiothixene (Navane) 5 L L L H
ButyrophenonesHaloperidol (Haldol) 2 L L L H
5HT2A
D2SDA
11-16 Stahl S M, Essential Psychopharmacology (2000)
![Page 4: M1 1 H1 conventional D2 - Brown University...Microsoft PowerPoint - Biomed 370-Treatment of Schizophrenia Author Bobs Computer Created Date 2/15/2005 7:53:34 AM ...](https://reader033.fdocuments.us/reader033/viewer/2022050105/5f43f2c7eab0cf19ff78db48/html5/thumbnails/4.jpg)
4
5HT-DA Interactions
11-17 Stahl S M, Essential Psychopharmacology (2000)
Substantia nigra
raphe nucleus
brake
brake
serotonin neuron
dopamine neuron
Substantia nigra
Raphe
dopamine
5HT2A receptor serotonin
5HT2A receptor
11-18 Stahl S M, Essential Psychopharmacology (2000)
mesocortical pathwayprimary dopamine deficiency
secondary dopamine deficiency
dopamine release
serotonin
SDA
11-27 Stahl S M, Essential Psychopharmacology (2000)
![Page 5: M1 1 H1 conventional D2 - Brown University...Microsoft PowerPoint - Biomed 370-Treatment of Schizophrenia Author Bobs Computer Created Date 2/15/2005 7:53:34 AM ...](https://reader033.fdocuments.us/reader033/viewer/2022050105/5f43f2c7eab0cf19ff78db48/html5/thumbnails/5.jpg)
5
5HT2A receptor
Nigrostriatal pathway
11-24 Stahl S M, Essential Psychopharmacology (2000)
5HT7
5HT6
5HT3
5HT2C
5HT1A
M1 H11
2
D1
D3D4
5HT2A
D2clozapine
11-37 Stahl S M, Essential Psychopharmacology (2000)
5HT7
1
25HT2A
D2risperidone
11-39 Stahl S M, Essential Psychopharmacology (2000)
![Page 6: M1 1 H1 conventional D2 - Brown University...Microsoft PowerPoint - Biomed 370-Treatment of Schizophrenia Author Bobs Computer Created Date 2/15/2005 7:53:34 AM ...](https://reader033.fdocuments.us/reader033/viewer/2022050105/5f43f2c7eab0cf19ff78db48/html5/thumbnails/6.jpg)
6
5HT6
5HT3
5HT2C
M1 H11
D1
D3D4
5HT2A
D2olanzapine
11-40 Stahl S M, Essential Psychopharmacology (2000)
5HT7
5HT6
H11
25HT2A
D2quetiapine
11-41 Stahl S M, Essential Psychopharmacology (2000)
5HT1DSRI
NRI
5HT7
5HT2C
5HT1A
1
D3
5HT2A
D2ziprasidone
11-43 Stahl S M, Essential Psychopharmacology (2000)
![Page 7: M1 1 H1 conventional D2 - Brown University...Microsoft PowerPoint - Biomed 370-Treatment of Schizophrenia Author Bobs Computer Created Date 2/15/2005 7:53:34 AM ...](https://reader033.fdocuments.us/reader033/viewer/2022050105/5f43f2c7eab0cf19ff78db48/html5/thumbnails/7.jpg)
7
Side effects of selected atypical agents
POSITIVE SYMPTOM PHARMACY
3rd line treatment
2nd line treatment
noncompliant (depot)
1st line treatment
in case of emergency
polypharmacy combos
D2 clozapine
D2
SDA
D2BZ
11-52 Stahl S M, Essential Psychopharmacology (2000)
Hierarchy of Treatment Goals in Medical Psychotherapy of Schizophrenia
• Acute Phase– Medical/neuropsychiatric assessment– Rapid symptom reduction– Reduce impact of episode on friends, family, housing, activities
• Convalescent Phase– Gain trust/alliance with family/caregivers– Assess and mobilize social supports– Ensure human service needs are met (food, clothing, housing)– Ensure safety and predictability of environment
• Adaptive Plateau– Establish therapeutic alliance/supportive treatment routine– Achieve effective maintenance medication regime
• Stable plateau– Psychoeducation: Promote illness self-management strategies, awareness
of relationship between stress and symptoms– Rehabilitation: Teach adaptive competencies